Skip to main content

Cerebrolysin vs Semax

Both Cerebrolysin and Semax are used for cognitive and neuroprotection. Here's how their evidence, dosing, and regulatory status actually compare.

Cerebrolysin

Evidence B

Cerebrolysin (porcine brain peptide complex)

A standardized mixture of low-molecular-weight peptides from porcine brain. Decades of stroke, dementia, and TBI trial data — modest but consistent cognitive recovery effects.

View full Cerebrolysin profile →

Semax

Evidence B

Semax (MEHFPGP)

A synthetic ACTH fragment that increases BDNF levels and enhances focus, memory, and mental clarity. Delivered intranasally for rapid cognitive effects.

View full Semax profile →

Side-by-Side

AttributeCerebrolysinSemax
Evidence GradeBB
FDA StatusNot FDA-approved in US — approved in 50+ countries for stroke, traumatic brain injury, and dementiaNot FDA-approved in US — approved in Russia for stroke and cognitive disorders
Typical DoseTrial range: 5–30 mL daily (intravenous infusion)200–600 mcg intranasal, morning
Clinics Indexed4189
Categoriescognitive, neuroprotectioncognitive, neuroprotection

Key reported benefits — Cerebrolysin

  • Stroke recovery support
  • TBI rehabilitation
  • Cognitive function in dementia

Key reported benefits — Semax

  • BDNF increase
  • Enhanced focus
  • Memory improvement
  • Neuroprotection

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons